News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Pulmovant (Roivant) will present topline Phase 2 PHocus results for mosliciguat in PH-ILD at the ERS Congress on Sept 8.
  • Roivant will host an investor call immediately after the ERS presentation to discuss the topline findings.
  • Topline results will affect Pulmovant and respiratory-biotech sector valuations.
  • Star Group offers a yield above 6% and has raised distributions for 14 consecutive years.
  • Star Group generates roughly $56.8M in free cash flow with an enterprise value below $600M.
  • SGU trades at about a 5.2 P/E and ~3.2 EV/EBITDA, framing it as a reversion/value trade for income investors.

Latest Articles

European gas edges higher as Strait of Hormuz shipping paralysis and low storage keep supply risks elevated

European gas edges higher as Strait of Hormuz shipping paralysis and low storage keep supply risks elevated

European wholesale gas prices rose modestly as continued disruptions to tanker transit through the Strait of Hormuz and a shortfall in underground storage outweighed a temporary easing in global yields. Traders saw Dutch futures hold above multi-month support while U.K. contracts strengthened amid concerns about near-term supply into North Sea hubs…

Seabridge Gold: A Patient Long with Asymmetric Upside

Seabridge Gold: A Patient Long with Asymmetric Upside

Seabridge Gold is a development-stage gold company with sizable long-life projects and a capital structure that can deliver big upside if permitting, financing or a major partner materializes. The stock looks fairly priced for the base case but offers an attractive asymmetric payoff if catalysts hit. This trade idea lays out a concrete entry, prote…

Hanmi Financial: Improving Fundamentals Support a Mid-Term Upgrade

Hanmi Financial: Improving Fundamentals Support a Mid-Term Upgrade

Hanmi Financial (HAFC) is showing steady earnings power, a conservative balance sheet and active capital returns. At roughly $31.15, the shares look positioned for a mid-term re-rating supported by continued buybacks, a raised dividend and low leverage. This trade idea lays out entry, target and stop along with the catalysts and risks that will det…

Buy ServiceNow Into AI Momentum: Tactical Swing for a Q3 Upside

Buy ServiceNow Into AI Momentum: Tactical Swing for a Q3 Upside

ServiceNow is positioned to report another AI-accelerated quarter. With a $29B backlog, $4.6B in free cash flow and improving technical momentum, the pieces point to a Q3 beat. This is a tactical swing long: enter at market, limit risk with a $115 stop, target $150 as investors re-rate durable AI workflow monetization.

Buy the Dip in Meta: A Structured Long Trade Around a Legal Overhang

Buy the Dip in Meta: A Structured Long Trade Around a Legal Overhang

Meta's shares have retraced sharply from last year's peak as a major child safety trial and broader market risk-off sentiment weigh on the name. At $550 today, the company still generates robust free cash flow ($40.98B) and trades at ~20x earnings, leaving room for upside if ad demand stabilizes and litigation proves containable. This note lays out…

Edesa Biotech Announces Pricing of $25.0 Million Public Offering

Edesa Biotech Announces Pricing of $25.0 Million Public Offering

Edesa Biotech, a clinical-stage biopharmaceutical company listed on Nasdaq, announced the pricing of an underwritten public offering expected to raise gross proceeds of approximately $25 million. The offering includes common shares and warrants, aimed at supporting general corporate purposes including working capital, capital expenditures, and adva…

Buy the Dip in Teradyne: Positioning for a Chip-Testing Supercycle

Buy the Dip in Teradyne: Positioning for a Chip-Testing Supercycle

Teradyne is benefiting from an AI-led memory and semiconductor cycle that is pushing test volume and complexity higher. Strong Q2 results and bullish guidance justify an upgraded buy, but near-term volatility and stretched multiples argue for a dip-entry approach. Trade plan included for a mid-term swing with clear entry, stop and target.

Elanco: New Product Momentum and a Balanced Long Trade Into 2027

Elanco: New Product Momentum and a Balanced Long Trade Into 2027

Elanco's recent quarterly beat, new emergency-use approvals, and continued pet-care tailwinds create a practical long trade with clearly defined entry, stop and target. The company trades at roughly $12.2B market cap, generates positive free cash flow, and carries moderate leverage - a setup where execution on product launches will control the next…

UiPath: Why the Turnaround Looks Convincing and a Practical Trade Plan

UiPath: Why the Turnaround Looks Convincing and a Practical Trade Plan

UiPath has moved from growth skepticism to hitting profitability, raising guidance and showing early success with agentic AI orchestration. With a market cap near $8.2B, attractive cash flow, improving margins and heavy short positioning, the risk/reward favors a tactical long over the next 45 trading days if ARR and execution continue to validate …

Rigetti Computing Establishes Dedicated Systems Delivery Organization to Scale Customer Deployments and Advance Quantum Processor Roadmap

Rigetti Computing Establishes Dedicated Systems Delivery Organization to Scale Customer Deployments and Advance Quantum Processor Roadmap

Rigetti Computing announced a new organizational structure creating a dedicated Systems Delivery organization to enhance scaling of on-premises quantum system deployments and establishing a Chief Operating Officer role to oversee operations, manufacturing, systems delivery, and customer engagement. The shift allows the Chief Technology Officer to f…